ITMI20042476A1 - Derivati indolici ad attivita' antitumorale - Google Patents

Derivati indolici ad attivita' antitumorale

Info

Publication number
ITMI20042476A1
ITMI20042476A1 IT002476A ITMI20042476A ITMI20042476A1 IT MI20042476 A1 ITMI20042476 A1 IT MI20042476A1 IT 002476 A IT002476 A IT 002476A IT MI20042476 A ITMI20042476 A IT MI20042476A IT MI20042476 A1 ITMI20042476 A1 IT MI20042476A1
Authority
IT
Italy
Prior art keywords
indulic
derivatives
antitumor activity
antitumor
activity
Prior art date
Application number
IT002476A
Other languages
English (en)
Inventor
Mara Cassin
Gennaro Colella
Munari Sergio De
Mario Grugni
Gianluca Pardi
Paolo Pavesi
Original Assignee
Cell Therapeutics Europe Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapeutics Europe Srl filed Critical Cell Therapeutics Europe Srl
Priority to IT002476A priority Critical patent/ITMI20042476A1/it
Publication of ITMI20042476A1 publication Critical patent/ITMI20042476A1/it
Priority to EP05849516A priority patent/EP1835908A2/en
Priority to MX2007007496A priority patent/MX2007007496A/es
Priority to CNA2005800440744A priority patent/CN101083983A/zh
Priority to US11/793,875 priority patent/US20090036441A1/en
Priority to ZA200704919A priority patent/ZA200704919B/xx
Priority to PCT/EP2005/013886 priority patent/WO2006066923A2/en
Priority to AU2005318418A priority patent/AU2005318418A1/en
Priority to CA002591980A priority patent/CA2591980A1/en
Priority to KR1020077014108A priority patent/KR20070102671A/ko
Priority to JP2007547363A priority patent/JP2008525356A/ja
Priority to IL184113A priority patent/IL184113A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
IT002476A 2004-12-23 2004-12-23 Derivati indolici ad attivita' antitumorale ITMI20042476A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT002476A ITMI20042476A1 (it) 2004-12-23 2004-12-23 Derivati indolici ad attivita' antitumorale
JP2007547363A JP2008525356A (ja) 2004-12-23 2005-12-22 抗腫瘍活性を有するインドール誘導体
US11/793,875 US20090036441A1 (en) 2004-12-23 2005-12-22 Indole Derivatives With Antitumor Activity
MX2007007496A MX2007007496A (es) 2004-12-23 2005-12-22 Derivados de indol con actividad antitumoral.
CNA2005800440744A CN101083983A (zh) 2004-12-23 2005-12-22 具有抗肿瘤活性的吲哚衍生物
EP05849516A EP1835908A2 (en) 2004-12-23 2005-12-22 Indole derivatives with antitumor activity
ZA200704919A ZA200704919B (en) 2004-12-23 2005-12-22 Indole derivatives with antitumor activity
PCT/EP2005/013886 WO2006066923A2 (en) 2004-12-23 2005-12-22 Indole derivatives with antitumor activity
AU2005318418A AU2005318418A1 (en) 2004-12-23 2005-12-22 Indole derivatives with antitumor activity
CA002591980A CA2591980A1 (en) 2004-12-23 2005-12-22 Indole derivatives with antitumor activity
KR1020077014108A KR20070102671A (ko) 2004-12-23 2005-12-22 항종양 활성을 갖는 인돌 유도체
IL184113A IL184113A0 (en) 2004-12-23 2007-06-21 Indole derivatives with antitumor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002476A ITMI20042476A1 (it) 2004-12-23 2004-12-23 Derivati indolici ad attivita' antitumorale

Publications (1)

Publication Number Publication Date
ITMI20042476A1 true ITMI20042476A1 (it) 2005-03-23

Family

ID=36088419

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002476A ITMI20042476A1 (it) 2004-12-23 2004-12-23 Derivati indolici ad attivita' antitumorale

Country Status (12)

Country Link
US (1) US20090036441A1 (it)
EP (1) EP1835908A2 (it)
JP (1) JP2008525356A (it)
KR (1) KR20070102671A (it)
CN (1) CN101083983A (it)
AU (1) AU2005318418A1 (it)
CA (1) CA2591980A1 (it)
IL (1) IL184113A0 (it)
IT (1) ITMI20042476A1 (it)
MX (1) MX2007007496A (it)
WO (1) WO2006066923A2 (it)
ZA (1) ZA200704919B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2559519T3 (es) 2010-12-22 2016-02-12 Université Catholique de Louvain Nuevos derivados de fenazina y su uso
ES2562903T3 (es) * 2011-07-13 2016-03-09 Santen Pharmaceutical Co., Ltd Nuevo compuesto que tiene actividad inhibidora de PARP
TR201809990T4 (en) * 2014-05-09 2018-08-27 Pimera Inc NEW COMPOSITIONS, USES AND METHODS FOR THEIR MAKING.
CN114436938B (zh) * 2022-01-26 2023-10-27 南京诺源医疗器械有限公司 一种吲哚菁绿药物中的杂质及其制备方法和应用
CN115850151A (zh) * 2022-11-25 2023-03-28 成都普康生物科技有限公司 一种席夫碱类似化合物及其合成方法、pi3k激酶抑制剂及其应用

Also Published As

Publication number Publication date
KR20070102671A (ko) 2007-10-19
IL184113A0 (en) 2008-12-29
AU2005318418A1 (en) 2006-06-29
ZA200704919B (en) 2008-09-25
CA2591980A1 (en) 2006-06-29
JP2008525356A (ja) 2008-07-17
US20090036441A1 (en) 2009-02-05
EP1835908A2 (en) 2007-09-26
WO2006066923A2 (en) 2006-06-29
WO2006066923A3 (en) 2006-10-26
MX2007007496A (es) 2007-10-10
CN101083983A (zh) 2007-12-05

Similar Documents

Publication Publication Date Title
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
MA29039B1 (fr) Dibenzylamines et derives
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
DE602005015466D1 (de) Antivirale 4'-azidonucleoside
IS8403A (is) Pýrrólafleiður með bakteríueyðandi virkni
DK1824856T3 (da) 2,4 (4,6)-pyrimidinderivater
MA28824B1 (fr) Derives de pyrimidine
ATE383361T1 (de) Pyrrazolopyrimidinderivate
MA28813B1 (fr) Derives de pyrimidine
ATE413389T1 (de) Chinazolinderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DK1854789T3 (da) Quinazolinderivat med tyrosin-kinase inhibitorisk aktivitet
IS2736B (is) Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni
DK1839662T3 (da) Antitumormiddel
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
ATE437856T1 (de) 5-aminoindol-derivate
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DK1740574T3 (da) 4-amino-5-cyanopyrimidinderivater
ITMI20042476A1 (it) Derivati indolici ad attivita' antitumorale
ITMI20040124A1 (it) Macrolidi ad attivita' antiinfiammatoria
ES1061567Y (es) "conjunto rodadero"
DE602005004827D1 (de) Lageranordnung
DE602005022201D1 (de) Lageranordnung